Personalized Breast Cancer Treatment
11 – 20 of 146
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
Engström, Terese ; Ekholm, Maria ; Fernö, Mårten LU ; Lundgren, Christine LU ; Nordenskjöld, Bo ; Stål, Olle ; Bendahl, Pär Ola LU ; Tutzauer, Julia LU
and Rydén, Lisa
LU
(2024)
In Acta Oncologica
63.
p.125-136
- Contribution to journal › Article
-
Mark
Health-related quality of life by type of breast surgery in women with primary breast cancer : prospective longitudinal cohort study
Gulis, Kim LU
; Ellbrant, Julia
LU
; Bendahl, Pär Ola
LU
; Svensjö, Tor
LU
and Rydén, Lisa
LU
(2024)
In BJS Open
8(3).
- Contribution to journal › Article
-
Mark
Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)
Skarping, Ida LU
; Ellbrant, Julia
LU
; Dihge, Looket
LU
; Ohlsson, Mattias
LU
; Huss, Linnea
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2024)
In BMC Cancer
24(1).
- Contribution to journal › Article
-
Mark
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer
Skarping, Ida LU
; Bendahl, Pär-Ola
LU
; Szulkin, Robert
; Alkner, Sara
LU
; Andersson, Yvette
; Bergkvist, Leif
; Christiansen, Peer
; Filtenborg Tvedskov, Tove
; Frisell, Jan
and Gentilini, Oreste D
, et al.
(2024)
In JAMA Surgery
159(12).
- Contribution to journal › Article
-
Mark
Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up
Fohlin, Helena ; Nordenskjöld, Anna ; Rosell, Johan ; Fernö, Mårten LU ; Fornander, Tommy ; Rydén, Lisa LU
; Skoog, Lambert
; Nordenskjöld, Bo
and Stål, Olle
(2024)
In Acta oncologica (Stockholm, Sweden)
63(1).
p.535-541
- Contribution to journal › Article
-
Mark
Clinical cell-surface targets in metastatic and primary solid cancers
- Contribution to journal › Article
- 2023
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
- Contribution to journal › Article
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
Gunnarsdottir, Frida Björk LU ; Bendahl, Pär Ola LU ; Johansson, Alexandra ; Benfeitas, Rui ; Rydén, Lisa LU
; Bergenfelz, Caroline
LU
and Larsson, Anna Maria
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
Gulis, K. LU
; Ellbrant, J.
LU
; Svensjö, T.
LU
; Skarping, I.
LU
; Vallon-Christersson, J.
LU
; Loman, N.
LU
; Bendahl, P. O.
LU
and Rydén, L.
LU
(2023)
In European Journal of Surgical Oncology
49(7).
p.1189-1195
- Contribution to journal › Article
-
Mark
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer : a long-term follow-up of the SweBCG91RT randomized trial
Egelberg, Moa LU
; De Marchi, Tommaso
LU
; Pekar, Gyula
LU
; Tran, Lena
LU
; Bendahl, Pär Ola
LU
; Tullberg, Axel Stenmark
; Holmberg, Erik
; Karlsson, Per
; Farnebo, Marianne
and Killander, Fredrika
LU
, et al.
(2023)
In Molecular Oncology
17(10).
p.2029-2040
- Contribution to journal › Article